Share your requirements to help us to customize the report.
   I acknowledge that I have read the Privacy Policy

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Analyst Support


Cell Culture Media Market size was valued at USD 4.9 billion in 2019 and is poised to grow from USD 5.68 billion in 2023 to USD 18.63 billion by 2031, growing at a CAGR of 16% in the forecast period (2024-2031).

cell culture media market is highly fragmented by numerous small manufacturers. Some of the major manufacturers include- Thermo Fisher Scientific Inc., Merck KGaA. Danaher Corporation, and Sartorius AG. These manufacturers are majorly focusing on expanding the growth of cell culture media with new product innovation. In order to provide industries with the most effective and economical solutions, these major market players are also continually concentrating on R&D. Besides, these companies offer a range of products in different applications to fulfill the required demand of consumers which is further contributing to healthy growth in the market. 'Thermo Fisher Scientific Inc.', 'Merck KGaA', 'GE Healthcare', 'Lonza Group AG', 'Corning Incorporated', 'BD (Becton, Dickinson and Company)', 'HiMedia Laboratories', 'Fujifilm Holdings Corporation (Irvine Scientific Sales Company)', 'CellGenix GmbH', 'PromoCell GmbH', 'Takara Bio, Inc.', 'Sera Scandia A/S', 'Bio-Rad Laboratories, Inc.', 'InVitria (Ventria Bioscience)', 'Biomimetics Sympathies AG', 'ZenBio, Inc.', 'Sartorius AG', 'Agilent Technologies, Inc.', 'Irvine Scientific', 'Atlanta Biologicals, Inc.'

Due to ethical issues there is an increase in demand for animal component-free media and automated cell culture systems. In traditional methods animals were used for clinical trials before being used on humans. Many non-governmental organizations are protesting against such companies.

Due to COVID-19 pandemic, researchers are trying to understand the biology of different virus variants to develop new therapeutic methods. This started in laboratory experiments to understand whether a drug can stop the virus from replicating in cells in a dish or whether a vaccine is effective on the virus.

North America accounts for the largest share of the cell culture media market of about 39.6% across the globe due to the rise in research & development investment. The pharmaceuticals and biotechnology industry is deeply investing to find out new innovative solutions and enhance patient care. In the U.S Biotech startups have raised a total of USD 47 billion in 2021, and in 2022 USD 16 billion is raised till date. USA holds the highest share of about 90% in the region

Feedback From Our Clients

Global Cell Culture Media Market

Product ID: SQMIG35H2057